|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 23, 2017 ) The North America NGS market which was worth $1.33 billion by the end of 2016 is estimated to reach $3.11 billion by 2021 at a CAGR of 18.6%.The Next Generation Sequencing market is categorized by product (software and services) and by applications. By product it is sub-segmented into whole targeted re-sequencing, genome sequencing, exome sequencing, de novo sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq. By application it is sub-segmented into diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture & animal research.
View Full Report @ http://www.marketdataforecast.com/market-reports/north-america-next-generation-sequencing-market-117/
On the basis of geography, the North America market is segmented into USA, Canada & Mexico regions. Rise in growth of personalized medicine, development in pre-sequencing and NGS bioinformatics solutions and cloud computing, growth in North American population, increasing incidence of infectious diseases and cancer are some of the factors driving the market growth. In addition, anticipated decrease in the prices of genome sequencing due to development of rapid, high capacity whole genome sequencers by key players is expected to show an optimistic effect on the market penetration rates over the few years. However, the storage and management of enormous data generated by sequencing and its interpretation,high reliability on grants & funding from the government and fall in capital expenditure from academic institutions are the key challenges faced by North America next generation sequencing market
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/north-america-next-generation-sequencing-market-117/request-sample
Illumina Incorporated, Thermo Fischer Scientific, Life Sciences (Roche),Pacific Biosciences, Life Technologies Corp. (Thermo Fischer Scientific), Macrogen Inc.,Partek Inc., Genomatix Software GmbH, Perkin Elmer inc.,GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd.,Pacific Biosciences, DNASTAR Inc., Knome Inc., Illumina Inc., and Qiagen N.V.
Inquire before Buying @ http://www.marketdataforecast.com/market-reports/north-america-next-generation-sequencing-market-117/inquire
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
